STOCKHOLM--(BUSINESS WIRE)--Apr 14, 2015--Regulatory News:
Elekta announced today that Providence Health & Services (Renton, Washington, USA) ?V the nation's third largest not-for-profit health system ?V has ordered multiple Elekta cancer management solutions, including radiation therapy systems and upgrades, oncology information systems and multiyear service contracts for its hospitals, clinics and other health care facilities in Washington, Alaska, California, Montana and Oregon.
In 2012, Providence and Seattle's Swedish Health Services affiliated, bringing together two of the region's largest health care organizations. The Swedish Cancer Institute was a long-time partner with Elekta in the provision of cancer management resources in the northwest.
"Our new partnership with Providence continues a mutually beneficial tradition in which two organizations work together to build value for thousands of individuals in this region who need world-class health care," says Jay Hoey, Executive Vice President, Elekta North America. "We're jointly creating something that is more than a traditional vendor-customer relationship ?V it's an alliance of two entities with a common vision to improve patients' lives."
In the agreement, Providence Health & Services will acquire several Versa HD??( http://www.versahd.com/ ) systems, Elekta's most advanced radiation therapy system (linear accelerator), featuring sophisticated beam shaping technology combined with high dose rate delivery. Versa HD is designed to give clinicians the flexibility to deliver conventional therapies to treat a wide range of small and large tumors throughout the body, while also enabling treatment of highly complex cancers that require extreme targeting precision.
In addition, Elekta will provide upgrades to several existing Elekta systems, including the integration of Agility??( http://www.elekta.com/agility ) 160-leaf multileaf collimator (MLC) and XVI (5.0)?( http://www.elekta.com/XVI ) software.
In a significant acquisition of Elekta software, Providence also will begin a system-wide conversion of its existing oncology information system to MOSAIQR?( http://www.elekta.com/MOSAIQ ) Oncology Information System.
Installation of the Elekta systems is set to begin immediately, continuing through the end of 2016.
For further information, please contact: Gert van Santen, Group Vice President Corporate Communications, Elekta AB Tel: +31 653 561 242, e-mail:? email@example.com Time zone: CET: Central European Time
Tobias Bulow, Director Financial Communication, Elekta AB Tel: +46?722?215 017, e-mail:? firstname.lastname@example.org Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on April 14, 2015.
About Elekta Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.
This information was brought to you by Cision http://news.cision.com
CONTACT: Elekta AB
Gert van Santen, +31 653 561 242
Group Vice President Corporate Communications
Tobias Bulow, +46?722?215 017
Director Financial Communication
KEYWORD: EUROPE SWEDEN
Copyright Business Wire 2015
PUB: 04/14/2015 02:02 AM/DISC: 04/14/2015 02:02 AM